Glycoprotein N-linked glycans play a critical role in arenavirus pathogenicity
Open Access
- 1 March 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 17 (3), e1009356
- https://doi.org/10.1371/journal.ppat.1009356
Abstract
Several arenaviruses cause hemorrhagic fevers in humans with high case fatality rates. A vaccine named Candid#1 is available only against Junin virus (JUNV) in Argentina. Specific N-linked glycans on the arenavirus surface glycoprotein (GP) mask important epitopes and help the virus evade antibody responses. However the role of GPC glycans in arenavirus pathogenicity is largely unclear. In a lethal animal model of hemorrhagic fever-causing Machupo virus (MACV) infection, we found that a chimeric MACV with the ectodomain of GPC from Candid#1 vaccine was partially attenuated. Interestingly, mutations resulting in acquisition of N-linked glycans at GPC N83 and N166 frequently occurred in late stages of the infection. These glycosylation sites are conserved in the GPC of wild-type MACV, indicating that this is a phenotypic reversion for the chimeric MACV to gain those glycans crucial for infection in vivo. Further studies indicated that the GPC mutant viruses with additional glycans became more resistant to neutralizing antibodies and more virulent in animals. On the other hand, disruption of these glycosylation sites on wild-type MACV GPC rendered the virus substantially attenuated in vivo and also more susceptible to antibody neutralization, while loss of these glycans did not affect virus growth in cultured cells. We also found that MACV lacking specific GPC glycans elicited higher levels of neutralizing antibodies against wild-type MACV. Our findings revealed the critical role of specific glycans on GPC in arenavirus pathogenicity and have important implications for rational design of vaccines against this group of hemorrhagic fever-causing viruses. Several arenaviruses cause severe hemorrhagic fevers in humans. The only vaccine against arenavirus infections is Candid#1, a live attenuated vaccine against Argentine hemorrhagic fever. So far, we have successfully attenuated additional one of the arenaviruses, Machupo virus, the causative agent of Bolivian hemorrhagic fever. Unraveling this attenuation mechanism might help the development of live-attenuated vaccines for other arenaviruses. In this study, we revealed that the specific glycans of the viral glycoproteins play an important role in pathogenicity in vivo. The glycans facilitate the virus to evade neutralizing antibodies. This study would contribute to the development of arenavirus vaccine candidates.Keywords
Funding Information
- Japan Society for the Promotion of Science (JSPS Postdoctoral Fellowship for Research Abroad (H28-803))
- Japan Society for the Promotion of Science (JSPS Postdoctoral Fellowship for Research Abroad (H29-296))
- Burroughs Wellcome Fund (Burroughs Wellcome Fund Career Award for Medical Scientists (2016))
This publication has 58 references indexed in Scilit:
- Vascular leak ensues a vigorous proinflammatory cytokine response to Tacaribe arenavirus infection in AG129 miceVirology Journal, 2013
- The Major Determinant of Attenuation in Mice of the Candid1 Vaccine for Argentine Hemorrhagic Fever Is Located in the G2 Glycoprotein Transmembrane DomainJournal of Virology, 2011
- Rescue from Cloned cDNAs and In Vivo Characterization of Recombinant Pathogenic Romero and Live-Attenuated Candid #1 Strains of Junin Virus, the Causative Agent of Argentine Hemorrhagic Fever DiseaseJournal of Virology, 2011
- Glycosylation modulates arenavirus glycoprotein expression and functionVirology, 2011
- Features and development of CootActa crystallographica. Section D, Structural biology, 2010
- Structural basis for receptor recognition by New World hemorrhagic fever arenavirusesNature Structural & Molecular Biology, 2010
- Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenavirusesProceedings of the National Academy of Sciences of the United States of America, 2008
- New World Clade B Arenaviruses Can Use Transferrin Receptor 1 (TfR1)-Dependent and -Independent Entry Pathways, and Glycoproteins from Human Pathogenic Strains Are Associated with the Use of TfR1Journal of Virology, 2008
- Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenavirusesNature, 2007
- Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spreadThe Journal of Experimental Medicine, 2006